Tuesday, February 26, 2019 10:26:02 AM
The value of biosynthesis.
The Baseline is $10-$100 per Gram of CBD depending on the size of your order and purity. Once you get away from the over the counter extracts and into the pharmaceutical grade the prices start to go up considerably. For >98% pure pharmaceutical grade research CBD in crystalline form, the price goes to $5-$10 per milligram.
CBD is or will become a commodity and we are more interested in the minor cannabinoids so I wanted to know what the market is. If there is a price to be found, there is a market to sell them. So I did a scan of a few chemical companies (Cayman Chemical, Sigma Aldrich and Toronto Research Chemicals) that provide research grade cannabinoid compounds and got some prices. I've listed about 55 Cannabinoids and put in prices where they could be found. Feel free to add in more if you can find them.
#8 is CBD and it's calculated in grams where everything else is in milligrams. Just for your reference Cayman Chemical sells 98% pure crystalline pharmaceutical-grade CBD for about $5 per milligram.
Long to short, there is some serious profit to be had!
Cannabichromenes
1. Cannabichromene (CBC) - $97 per mg
2. Cannabichromenic acid (CBCA) - $249 per mg
3. Cannabichromevarin (CBCV) - $195 per mg
4. Cannabichromevarinic acid (CBCVA) - $4000 per 100mg
Cannabicyclols
5. Cannabicyclol (CBL) $95 per mg
6. Cannabicyclolic acid (CBLA) $151 per 0.5mg in 1 ML - $302 per mg
7. Cannabicyclovarin (CBLV) price not public - via RFQ only
Cannabidiols
8. Cannabidiol (CBD) 98% pure - $5 per mg
9. Cannabidiol monomethylether (CBDM)
10. Cannabidiolic acid (CBDA) - $159 per mg
11. Cannabidiorcol (CBD-C1) - $20 per mg - $700 per 50 mg.
12. Cannabidivarin (CBDV) - $65 per 1mg to $149 per mg certified
13. Cannabidivarinic acid (CBDVA) - $275 per 1 ML / 1mg
Cannabielsoins
14. Cannabielsoic acid B (CBEA-B)
15. Cannabielsoin (CBE) - $100 per 1mg
16. Cannabielsoin acid A (CBEA-A)
Cannabigerols
17. Cannabigerol (CBG) - $95 per mg
18. Cannabigerol monomethylether (CBGM)
19. Cannabigerolic acid (CBGA) - $125 - 165 per mg
20. Cannabigerolic acid monomethylether (CBGAM)
21. Cannabigerovarin (CBGV) - $89 per mg
22. Cannabigerovarinic acid (CBGVA) - $128 per mp
Cannabinols and cannabinodiols
23. Cannabinodiol (CBND) - $65 per mg
24. Cannabinodiol (CBVD)
25. Cannabinol (CBN)- $32 - 65 per mg
26. Cannabinol methylether (CBNM) - $65 per mg
27. Cannabinol-C2 (CBN-C2)
28. Cannabinol-C4 (CBN-C4)
29. Cannabinolic acid (CBNA) $263 per 1 ML / 1mg
30. Cannabiorcool (CBN-C1)
31. Cannabivarin (CBV) $95 per 1mg
Cannabitriols - pricing unknown
32. 10-Ethoxy-9-hydroxy-delta-6a-tetrahydrocannabinol
33. 8,9-Dihydroxy-delta-6a-tetrahydrocannabinol
34. Cannabitriol (CBT)
35. Cannabitriolvarin (CBTV)
Delta-8-tetrahydrocannabinols
36. Delta-8-tetrahydrocannabinol (?8-THC) - $32-60 per mg
37. Delta-8-tetrahydrocannabinolic acid (?8-THCA)
Delta-9-tetrahydrocannabinols
38. Delta-9-tetrahydrocannabinol (THC) -
39. Delta-9-tetrahydrocannabinol-C4 (THC-C4)
40. Delta-9-tetrahydrocannabinolic acid A (THCA-A) - $149 per mg
41. Delta-9-tetrahydrocannabinolic acid B (THCA-B)
42. Delta-9-tetrahydrocannabinolic acid-C4 (THCA-C4)
43. Delta-9-tetrahydrocannabiorcol (THC-C1)
44. Delta-9-tetrahydrocannabiorcolic acid (THCA-C1)
45. Delta-9-tetrahydrocannabivarin (THCV) - $179 per mg
46. Delta-9-tetrahydrocannabivarinic acid (THCVA)
Miscellaneous cannabinoids
47. 10-Oxo-delta-6a-tetrahydrocannabinol (OTHC)
48. Cannabichromanon (CBCF)
49. Cannabifuran (CBF)
50. Cannabiglendol
51. Cannabiripsol (CBR)
52. Cannbicitran (CBT) - $100 per mg.
53. Dehydrocannabifuran (DCBF)
54. Delta-9-cis-tetrahydrocannabinol (cis-THC)
55. Tryhydroxy-delta-9-tetrahydrocannabinol (triOH-THC)
https://www.cantechletter.com/2019/02/the-future-of-cannabis-is-in-the-lab-says-altacorp-capital/
https://insiderfinancial.com/inmed-pharmaceuticals-inc-otcmktsimlff-comeback-trail
Bottom Line we are literally a few quarters from disrupting the whole industry with Inmed Pharma bio synthesis platform. This has massive upside potential 100-200x ROI
Recent INM News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 08:20:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 08:20:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 08:20:23 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 08:27:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 06:38:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 07:58:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2024 10:05:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 05:34:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 07:33:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 07:12:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 06:09:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 06:09:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 06:09:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 06:08:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 06:07:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 06:07:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 06:05:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 06:04:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/26/2023 06:04:18 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 12/21/2023 10:21:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/06/2023 02:02:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 07:50:14 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/14/2023 05:15:29 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/13/2023 10:05:08 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 11/08/2023 10:05:26 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM